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Deposition velocities of airborne microbe-
carrying particles
Introduction
In cleanrooms and hospital operating rooms, the high
efficiency filtration of the air supply to the room ensures that
no microbe-carrying particles (MCPs) enter a room in the
supply air. Also, these ventilated rooms are normally
positively pressurised with respect to adjacent areas, and this
ensures that few MCPs enter from outside. Therefore,
airborne MCPs in ventilated rooms are generated within the
room and most, if not all, come from personnel.
Micro-organisms grow on the cells and glands of the skin,
and are dispersed into the air on skin detritus. Skin cells have
been reported by Mackintosh et al.1 to have a top surface area
of approximately 33 µm × 44 µm, and 3 to 5 µm thick. They
may be found in the air either as whole cells, or fragments of
cells. Particles found in room air will vary in size, shape and
density, and their size is normally given as an equivalent
particle diameter, which is the diameter of a sphere of unit
density that settles in air at the same velocity as the particle
under consideration. Noble, Lidwell and Kingston2 have
reported that the average equivalent particle diameter of
MCPs in hospital air is about 12 µm, and Whyte and Hejab3
have confirmed this during experiments carried out on people
exercising in a dispersal chamber.
MCPs may deposit from the air onto surgical wounds
and products manufactured in cleanrooms and, based on
results published by Whyte4, a deposition velocity of
0.46 cm/s has been used to calculate airborne deposition of
MCPs onto pharmaceutical products5. However, recent
research by Whyte, Agricola and Derks6 carried out on
airborne particles in a cleanroom has shown that the
deposition velocity of particles increases as the air
cleanliness increases. It was, therefore, decided that a fresh
investigation of the values of deposition velocities of MCPs
was desirable. Sampling results had been gathered over a
number of years in pharmaceutical cleanrooms and
operating theatres, and were available to calculate the
deposition velocity of MCPs, and ascertain if it varied with
airborne cleanliness. 
Deposition of particles onto surfaces
The number of MCPs that will deposit onto a surface, such as
manufactured products, open surgical wounds, or settle
plates, can be calculated by use of the following equation5,6.
The deposition velocity of airborne microbe-carrying particles (MCPs) falling towards surfaces was
obtained experimentally in operating theatres and cleanrooms. The airborne concentrations of
MCPs, and their deposition rate onto surfaces, are related by the deposition velocity, and
measurements made by a microbial air sampler and settle plates allowed deposition velocities to be
calculated. The deposition velocity of MCPs was found to vary with the airborne concentration, with
higher deposition rates occurring at lower airborne concentrations. Knowledge of the deposition
velocity allows the deposition on surfaces, such as product or settle plates, by a known airborne
concentration of MCPs to be predicted, as well as the airborne concentration that should not be
exceeded for a specified product contamination rate. The relationship of airborne concentration and
settle plate counts of MCPs used in Annex 1 of the EU Guidelines to Good Manufacturing Practice to
specify grades of pharmaceutical cleanrooms was reassessed, and improvements suggested.
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Equation 1
Number of MCPs deposited = c*a*t*vD
Where c = airborne concentration of MCPs, a = area of
deposition surface, t = deposition time, and vD =
deposition velocity
If Equation 1 is rewritten in terms of the airborne
concentration of MCPs, the airborne concentration can be
calculated that should not be exceeded for a specified and
acceptable amount of surface deposition. Both these
methods of calculation are described by Whyte, Agricola
and Derks7. However, to complete these calculations, the
deposition velocity of airborne particles must be known. 
A useful approach to the investigation of the surface
deposition and deposition velocity of MCPs is use of the
microbial deposition rate (MDR), which is the deposition
rate of MCPs onto a standard surface area in a standard
time and can be obtained from counts on settle plates.
Settle plates of 9 cm diameter (64 cm2 surface area) are
most commonly used in cleanrooms, but settle plates of 14
cm diameter (154 cm2 surface area) are also used, as they
are more sensitive, as are several 9 cm plates. If the
number of MCPs that deposit onto a settle plate of known
area, exposed for a known time, is ascertained, then the
MDR (no./m2/s) can be obtained by calculating the
number of MCPs that will deposit onto one square metre
in one second. This approach allows Equation 1 to be
transformed to the following Equation 2.
Equation 2
MDR = c * vD
Rearranging Equation 2 gives the following Equation 3.
Equation 3
MDR
vD = 111
c
Use of Equation 3 allows the deposition velocity of MCPs
in a ventilated room to be ascertained by simultaneously
measuring, at the same location, the airborne concentration
with an air sampler and the MDR with a settle plate. 
Annex 1 of the European Union Guidelines to Good
Manufacturing Practice (EU GGMP)8 specifies grades of
cleanrooms with maximum concentrations of particles
and MCPs. These include maximum airborne
concentrations of MCPs/m3 and settle plate counts of
MCPs deposited onto a 90 mm diameter plate in 4 hours.
The settle plate counts for a given airborne concentration
of MCPs were based on information published in 1989
by the Parenteral Society (now the Pharmaceutical and
Healthcare Sciences Society) Technical Monograph No
29 that used an equation published by Whyte4 that is
similar to Equation 1 and used a deposition velocity of
0.46 cm/s. A reappraisal of the deposition velocities of
MCPs in this article gives an opportunity to reconsider
the maximum settle plate counts given in the EU GGMP
for different grades of pharmaceutical cleanrooms.
Experimental methods
Cleanrooms and operating rooms studied
Experiments were carried out in three pharmaceutical
manufacturing rooms in which the air supply, the number
of people present, and clothing worn, were varied to
obtain a range of airborne concentrations of MCPs. Two
hospital operating theatres were also studied. The rooms
studied were as follows.
(1) Vial-filling cleanroom: This cleanroom was a non-
unidirectional airflow (non-UDAF) cleanroom that
was supplied with approximately 20 air changes per
hour, and the vial filling carried out in a horizontal
UDAF cabinet.
(2) Diagnostics cleanroom: This was a non-UDAF
cleanroom supplied with 18 air changes per hour. The
air quality of the room could be enhanced by use of a
free-standing UDAF unit of 1.8 m × 0.7 m surface area
with an air supply velocity of 0.3 m/s.
(3) Ampoule-filling cleanroom: This cleanroom had a
floor area of 175 m2 and about 25 air changes per hour.
Vertical UDAF units were fitted over two ampoule
filling areas.
(4) Non-UDAF operating theatre: This was used for
orthopaedic surgery and was 6.1 m × 6.1 m in floor
area, with an air change rate of about 22 per hour.
(5) UDAF operating theatre enclosure: Orthopaedic
surgery was carried out within a UDAF enclosure
located in a non-UDAF operating room. The UDAF
enclosure had a high-efficiency particulate air filter
ceiling that was 3 m × 4 m in area and had a downward
air velocity of 0.3 m/s.
The cleanroom clothing worn in the pharmaceutical
cleanrooms was made from a woven polyester fabric and
consisted of a coverall, hood and knee-length over-boots,
a mask and sterile gloves. When higher airborne microbial
counts were required, either cotton garments or normal
indoor clothing was worn. Further increases in the
airborne concentration of MCPs were obtained by
introducing additional personnel into the room.
In the non-UDAF operating theatre, the surgical
clothing consisted of sterile cotton gowns worn over
cotton shirts and trousers. In the UDAF enclosure, non-
woven fabric gowns were worn over cotton shirts and
trousers. Hoods, face masks and sterile gloves were worn
in both theatres.
Air sampling methods 
Microbial sampling in the pharmaceutical cleanrooms was
carried out during microbial growth media (broth)
experiments for the filling of either vials or ampoules. In
the diagnostics preparation cleanroom, microbial
monitoring was undertaken during normal production
activities, but when the room ventilation was switched off,
Table 1. Experimental conditions and results.
Number Cleanroom/ Room UDAF Type of MCP Settle plate MDR Deposition
operating ventilation clothing volumetric count 14 cm (no./m2/s) velocity
theatre count diameter (cm/s)
application (no./m3) (no./h)
1 Vial filling On Horizontal – on Cleanroom 0.4 0.76 0.014 3.43
2 Vial filling On Off Cleanroom 85 8.5 0.15 0.18
3 Vial filling Off Off Cotton 186 42.6 0.77 0.41
4 Diagnostics On None Cleanroom 15.9 1.3 0.023 0.15
5 Diagnostics On Free-standing Cleanroom 1.8 3.3 0.060 3.31
UDAF
6 Diagnostics Off None Indoor* 1116 106 1.9 0.17
7 Ampoule filling Off Off Indoor† 118 14.6 0.26 0.22
8 Ampoule filling On Off Indoor 15 6 0.11 0.72
9 Orthopaedic On None Cotton 539 128 2.3 0.43
surgery
10 Orthopaedic On On Non-woven 3.8 1.3 0.023 0.62
surgery
* 10 people present; † 8 people present.
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or additional personnel wearing indoor clothing were
introduced, production activities were suspended, and
monitoring undertaken with personnel moving about and
active within the cleanroom. In the operating theatres,
sampling was carried out during routine orthopaedic
surgical operations.
Airborne MCPs were sampled by means of a slit
sampler (Casella Ltd) that sampled 700 litres of air per
minute onto Petri dishes containing tryptone soya agar
(Oxoid Ltd). After use, the Petri dishes were incubated
for 36 to 48 hours at 37°C and the microbial colonies
counted. To the air intake of the sampler, a 60 cm length
of 10 cm diameter flexible tubing was added that was
bent through 90° to the horizontal, and connected to a
sterile metal cone which converged to a 4 cm opening
through which air samples were drawn. This allowed
airborne MCPs to be efficiently sampled at the locations
where containers were filled or close to the surgical
wound, but where the sampler was too large to be placed.
Sampling times varied from 0.5 minutes to 15 minutes,
depending on the expected MCP counts, and sampling
was carried out over 2 and 5-hour periods in the same
day. In the case of pharmaceutical manufacturing,
samples were taken at both the vial and ampoule turntable
Figure 1. Relationship of MDR and airborne concentration of MCPs.
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and filling point, and an average calculated. During
surgical operations, samples were taken within 20 cm of
the open wound.
Settle plate sampling was carried out at the same time
as sampling with an air sampler, using 14 cm diameter
Petri dishes containing tryptone soya agar, which were
incubated after use for 36 to 48 hours at 37°C and the
microbial colonies counted. The settle plates were laid out
in the pharmaceutical cleanrooms on the filling machine
close to the filling area. Plates were exposed when filling
started and the lids replaced when filling stopped; this
exposure time varied from between 2 and 5 hours. During
the surgical operations, the open settle plate was placed
within 20 cm of the wound for the time between incision
and closure, and, depending on the operation, exposed for
between about 1 and 2 hours.
Experimental results
Given in Table 1 are the type of cleanrooms and operating
theatres studied. Also included are the MCP air
concentrations/m3, the number of MCPs that deposited
onto a 14 cm diameter settle plate per hour, and the MDR
(number/m2/s). The average deposition velocity of MCPs
calculated by Equation 3 is also included but given in the
more commonly used units of cm/s. 
Shown in Figure 1 is the relationship of the airborne
concentration to the MDR, with a regression line that best
fits the results. The equation of this line is as follows.
Equation 4
y  = 0.0161 x0.6571
Where y = MDR (no/m2/s), and x = airborne MCP
concentration/m3
Equation 4 was used to calculate the expected MDR for a
range of airborne MCP concentrations, and from these
results the deposition velocity (cm/s) was calculated by
means of Equation 3. These results are given in Table 2.
Shown in the first two columns of Table 3 are the
maximum airborne concentrations and settle plate
counts given in Annex 1 of the most recent edition of the
EU GGMP (2008) for different grades of cleanrooms.
Using the deposition velocities given in Table 2, the
number of MCPs expected to deposit onto a settle plate
of 9 cm diameter (area = 0.0064 m2) during an exposure
time of 4 hours, was calculated for the airborne
concentrations given in Table 3. Finally, in the last
column of Table 3 are the required settle plate results,
given as the MDR, using the base units of the
International System of Units (SI units), i.e. no./m2/s.
The MDR allows the number of MCPs deposited onto
any size of settle plate, in any time of exposure, to be
calculated.
Discussion and conclusions
Knowledge of the deposition velocity of MCPs as they fall
through the air onto cleanroom surfaces allows the
calculation of the amount of deposition on a surface such
as a product, as well as the airborne concentration that
should not be exceeded for a specified amount of product
contamination. These two calculation methods are
described by Whyte, Agricola and Derks7.
The deposition velocity of a range of particle sizes in
a cleanroom was ascertained by Whyte, Agricola and
Derks6 who reported that as the concentration of
airborne particles in the cleanroom decreased, the
deposition velocity increased. The reason for this was
not clear but it was suggested that as lower particle
concentrations were associated with higher air supply
rates, smaller particles would be quickly swept from the
cleanroom with little time to deposit, but larger particles
would still be deposited by gravity. This effect was
Table 3. EU GGMP recommended limits for air concentrations and settle plate counts. Present and corrected information.
Grade Air sample Settle plates Settle plates Corrected settle
cfu/m3 (diameter 90 mm) (diameter 90 mm) plate counts
cfu/4 hours cfu/4 hours as MDR (cfu/m2/s)
Current requirements Corrected requirements 
A <1 <1 <1.5 0.016
B 10 5 7 0.073
C 100 50 30 0.33
D 200 100 48 0.52
Table 2. Deposition velocities for airborne concentrations of
MCPs.
Airborne Deposition
concentration/m3 velocity (cm/s)
0.1 3.55
0.5 2.04
1 1.61
5 0.93
10 0.73
50 0.42
100 0.33
200 0.26
500 0.19
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expected to increase as the average residence time of the
air reduces owing to an increase in air supply rates. It
was also thought that an increase in the turbulent
intensity of the air, caused by an increase in the air
supply, would also increase the amount of surface
deposition. 
It is known that MCPs in cleanroom air do not
normally exist as single-celled organisms but are
commonly found on skin cells dispersed by personnel and
have an equivalent particle size of about 12 µm. The
deposition velocity of these MCPs had been reported by
Whyte4 to be about 0.46 cm/s, and this velocity has been
used in several articles, such as that published by Whyte
and Eaton5 to calculate the contamination rate of products
in cleanrooms. However, the results of the investigation
carried out by Whyte, Agricola and Derks6 has questioned
the accuracy of the use of a single deposition velocity
over a range of the cleanliness conditions found in a
cleanroom. 
The measurement of airborne concentrations and settle
plate counts was carried out in a wide variety of
cleanrooms and operating theatres. This data was
analysed and the deposition velocities of MCPs obtained.
These results showed that the deposition velocity
increased as the airborne concentration in the rooms
decreased, and the use of these deposition velocities
should improve the accuracy of the calculation of surface
contamination, as well as the calculation of the
concentration of airborne MCPs required to ensure that
microbial deposition of surfaces is not greater than
specified.
The EU GGMP specifies grades of cleanroom for use
in pharmaceutical manufacturing, and gives suggested
limits of the airborne concentrations and settle plate
counts of MCPs. The settle plate counts that correspond to
the airborne concentrations were derived from data
originally published in the Parenteral Society9 and based
on the equation published by Whyte4, which used a single
deposition velocity of 0.46 cm/s. Using the set of more
accurate deposition velocities, the EU GGMP maximum
concentrations can be revised to provide more accurate
settle plate counts. Table 3 shows the settle plate counts
currently specified by the EU GGMP and those based on
the information obtained in this article. It is suggested that
the EU GGMP should be revised to take account of these
findings.
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